Surgery Partners, Inc. (SGRY) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
310 SEVEN SPRINGS WAY BRENTWOOD, TN 37027 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8062 - General Medical and Surgical Hospitals (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 270 | 196 | 283 | 390 | 318 | 93 | |||
| Cash and cash equivalent | 270 | 196 | 283 | 390 | 318 | 93 | |||
| Receivables | 579 | 496 | 456 | 430 | 382 | 327 | |||
| Inventory, net of allowances, customer advances and progress billings | 88 | 75 | 71 | 61 | 56 | 46 | |||
| Inventory | 88 | 75 | 71 | 61 | 56 | 46 | |||
| Prepaid expense | 36 | 31 | 31 | 26 | 18 | 18 | |||
| Other current assets | 146 | 97 | 79 | 39 | 27 | 42 | |||
| Total current assets: | 1,119 | 895 | 921 | 946 | 802 | 526 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 656 | 587 | 530 | 330 | 258 | 237 | |||
| Operating lease, right-of-use asset | 296 | 255 | 279 | 324 | 310 | ||||
| Long-term investments and receivables | 215 | 184 | 190 | 89 | 90 | 93 | |||
| Long-term investments | 215 | 184 | 190 | 89 | 90 | 93 | |||
| Intangible assets, net (including goodwill) | 5,114 | 4,381 | 4,179 | 3,956 | 3,515 | 3,450 | |||
| Goodwill | 5,068 | 4,326 | 4,137 | 3,912 | 3,468 | 3,402 | |||
| Intangible assets, net (excluding goodwill) | 46 | 55 | 42 | 44 | 47 | 47 | |||
| Other undisclosed intangible assets, net (including goodwill) | |||||||||
| Restricted cash and investments | 0 | 0 | |||||||
| Estimated insurance recoveries | 10 | 10 | 13 | 9 | 11 | 12 | |||
| Deferred income tax assets | 90 | 92 | 114 | 125 | 99 | ||||
| Other noncurrent assets | 58 | 103 | 144 | 59 | 27 | 329 | |||
| Other undisclosed noncurrent assets | 423 | 372 | 334 | 291 | 276 | 274 | |||
| Total noncurrent assets: | 6,771 | 5,982 | 5,761 | 5,172 | 4,612 | 4,493 | |||
| TOTAL ASSETS: | 7,890 | 6,877 | 6,682 | 6,118 | 5,413 | 5,019 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 269 | 246 | 221 | 202 | 166 | 151 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 77 | 65 | 54 | ||
| Accounts payable | 209 | 172 | 152 | 125 | 100 | 97 | |||
| Accrued liabilities | 60 | 74 | 69 | ||||||
| Debt | 101 | 73 | 63 | 60 | 64 | 56 | |||
| Other liabilities | 254 | 204 | 207 | 210 | 217 | 191 | |||
| Other undisclosed current liabilities | 3 | 64 | 110 | ||||||
| Total current liabilities: | 624 | 523 | 493 | 537 | 557 | 398 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 3,269 | 2,702 | 2,559 | 2,878 | 2,792 | 2,525 | |||
| Finance lease, liability | 766 | 668 | 565 | 346 | 262 | 238 | |||
| Other undisclosed long-term debt and lease obligation | 2,503 | 2,034 | 1,994 | 2,217 | 2,229 | 2,004 | |||
| Liabilities, other than long-term debt | 362 | 290 | 347 | 87 | 201 | 397 | |||
| Deferred income tax liabilities | 39 | ||||||||
| Other liabilities | 30 | 41 | 75 | 87 | 140 | 397 | |||
| Operating lease, liability | 292 | 249 | 271 | 316 | 301 | 283 | |||
| Derivative instruments and hedges, liabilities | 61 | ||||||||
| Other undisclosed noncurrent liabilities | 316 | 240 | |||||||
| Total noncurrent liabilities: | 3,630 | 2,992 | 2,906 | 3,281 | 3,233 | 2,921 | |||
| Total liabilities: | 4,255 | 3,515 | 3,399 | 3,818 | 3,790 | 3,320 | |||
| Temporary equity, including noncontrolling interest | 439 | 327 | 342 | 330 | 741 | 716 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 1,790 | 1,987 | 1,998 | 1,089 | 116 | 297 | |||
| Additional paid in capital | 2,521 | 2,498 | 2,478 | 1,622 | 608 | 663 | |||
| Accumulated other comprehensive income (loss) | 5 | 58 | 76 | (32) | (61) | (51) | |||
| Accumulated deficit | (737) | (569) | (557) | (503) | (432) | (316) | |||
| Other undisclosed equity, attributable to parent | 1 | 1 | 1 | 1 | 1 | 1 | |||
| Equity, attributable to noncontrolling interest | 1,407 | 1,047 | 943 | 881 | 767 | 687 | |||
| Total equity: | 3,196 | 3,035 | 2,941 | 1,970 | 882 | 983 | |||
| TOTAL LIABILITIES AND EQUITY: | 7,890 | 6,877 | 6,682 | 6,118 | 5,413 | 5,019 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 3,114 | 2,743 | 2,539 | 2,225 | 1,860 | 1,831 | ||
| Cost of revenue | (1,408) | |||||||
| Gross profit: | 3,114 | 2,743 | 2,539 | 2,225 | 1,860 | 424 | ||
| Operating expenses | (2,766) | (2,415) | (2,194) | (1,923) | (1,677) | (116) | ||
| Other operating income, net (Other Nonrecurring (Income) Expense) | 1 | |||||||
| Other undisclosed operating loss | (74) | |||||||
| Operating income: | 349 | 328 | 345 | 302 | 183 | 236 | ||
| Interest and debt expense | (62) | (49) | (43) | (37) | (22) | (13) | ||
| Income from continuing operations before equity method investments, income taxes: | 287 | 279 | 303 | 266 | 161 | 223 | ||
| Income from equity method investments | 11 | 11 | ||||||
| Income from continuing operations before income taxes: | 287 | 279 | 303 | 277 | 172 | 223 | ||
| Income tax expense (benefit) | (135) | 0 | (23) | (11) | 20 | (10) | ||
| Income from continuing operations: | 152 | 280 | 279 | 267 | 192 | 213 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 267 | 192 | 213 | |
| Other undisclosed net loss | (140) | (144) | (192) | (196) | (190) | (168) | ||
| Net income: | 13 | 135 | 87 | 71 | 1 | 45 | ||
| Net loss attributable to noncontrolling interest | (181) | (147) | (142) | (142) | (117) | (120) | ||
| Net loss attributable to parent: | (168) | (12) | (55) | (71) | (116) | (75) | ||
| Undistributed earnings (loss) allocated to participating securities, basic | (10) | (40) | (36) | |||||
| Net loss available to common stockholders, diluted: | (168) | (12) | (55) | (81) | (156) | (111) | ||
Comprehensive Income ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 13 | 135 | 87 | 71 | 1 | 45 | ||
| Net loss attributable to redeemable noncontrolling interest | (37) | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other comprehensive income (loss) | (53) | (19) | 108 | 30 | (10) | (28) | ||
| Other undisclosed comprehensive loss | ||||||||
| Comprehensive income (loss): | (40) | 117 | 195 | 100 | (9) | 17 | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (181) | (147) | (142) | (142) | (117) | (120) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (221) | (31) | 53 | (41) | (126) | (103) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.